Position history for Avoro Capital Advisors LLC's holdings in OCULAR THERAPEUTIX INC
Avoro Capital Advisors LLC holds 12.3M shares of OCUL (OCULAR THERAPEUTIX INC), worth $104.3M as of 2026-Q1. The position was increased (+14.3% shares). OCUL represents 1.0% of Avoro Capital Advisors LLC's portfolio.
Current Value
$104.3M
Current Shares
12.3M
Total Value Change
+$49.2M
Total Shares Change
+4.3M
Other major holders of OCUL: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 12.3M |
+14.3% |
| $104.3M |
| 1.0% |
| $10.76 |
55 |
| 2025-Q4 | Increased | 10.8M | +5.2% | $130.8M | 1.3% | $12.20 | 51 |
| 2025-Q3 | Increased | 10.3M | +38.5% | $119.8M | 1.5% | $12.53 | 63 |
| 2025-Q2 | Decreased | 7.4M | -8.2% | $68.7M | 1.2% | $9.22 | 0 |
| 2025-Q1 | Unchanged | 8.1M | 0.0% | $59.1M | 0.9% | $7.58 | 0 |
| 2024-Q4 | Unchanged | 8.1M | 0.0% | $68.8M | 1.0% | $8.35 | 0 |
| 2024-Q3 | Unchanged | 8.1M | 0.0% | $70.1M | 1.0% | $8.68 | 0 |
| 2024-Q2 | Increased | 8.1M | +12.7% | $55.1M | 0.7% | $6.84 | 48 |